Aries Bordetella Assay, REF 50-10037, UDI # 00840487101452
FDA Device Recall #Z-2282-2019 — Class II — February 20, 2019
Recall Summary
| Recall Number | Z-2282-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 20, 2019 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Luminex Corporation |
| Location | Austin, TX |
| Product Type | Devices |
| Quantity | N/A |
Product Description
Aries Bordetella Assay, REF 50-10037, UDI # 00840487101452
Reason for Recall
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
Distribution Pattern
US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom
Lot / Code Information
Lot numbers and discontinue use by date for Part Number 50-10037: AA7125 - Immediately, AA7310 - Immediately, AA7548 - 3/13/2019, AA7633 - 4/12/2019
Other Recalls from Luminex Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1903-2025 | Class II | VERIGENE Gram Negative Blood Culture (BC-GN) Nu... | Apr 16, 2025 |
| Z-2533-2024 | Class II | Verigene Gram Positive Blood Culture (BC-GP) Nu... | Jun 20, 2024 |
| Z-0500-2024 | Class II | Luminex VERIGENE BC-GP Utility Tray (5-Pack Car... | Nov 7, 2023 |
| Z-2023-2023 | Class II | Verigene Enteric Pathogens Nucleic Acid Test (E... | Jun 5, 2023 |
| Z-2024-2023 | Class II | VERIGENE Clostridium difficile Nucleic Acid Tes... | Jun 5, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.